NSWIn ForceRegulation
Poisons and Therapeutic Goods Regulation 2008
174AInterpretation
Start here
Get a plain-English read of 174A
Turn the raw legal text into a practical explanation grounded in Poisons and Therapeutic Goods Regulation 2008.
#### 174A Interpretation
174A Interpretation
> In this Part—
>
> data source entity means—
>
> > (a) the Australian Health Practitioner Regulation Agency established by section 23 of the [Health Practitioner Regulation National Law (NSW)](/view/html/inforce/current/act-2009-86a), or
>
> > (b) eRx Script Exchange Pty Ltd, or
>
> > (c) Fred IT Group Pty Ltd, or
>
> > (d) Medication Knowledge Pty Ltd, or
>
> > (e) MediSecure Ltd, or
>
> > (f) any prescription exchange service prescribed by, or otherwise recognised for the purposes of, a law of the Commonwealth or another State or Territory.
>
> database means the database established under clause 174C.
>
> healthcare identifier means the healthcare identifier assigned to a person or an organisation under the [Healthcare Identifiers Act 2010](http://www.legislation.gov.au/) of the Commonwealth.
>
> monitored medicine means a substance listed in Appendix E.
>
> prescriber means an authorised practitioner, other than a veterinary practitioner.
>
> regulatory authority means an entity—
>
> > (a) with functions that include the regulation of monitored medicines or the regulation of health practitioners, and
>
> > (b) that is established under a law of—
> >
> > > (i) New South Wales, or
> >
> > > (ii) another State or Territory, or
> >
> > > (iii) the Commonwealth.
>
> **cl 174A:** Ins 2021 (134), Sch 1\[1\]. Am 2023 (302), Sch 1\[9\].